nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—NR3C1—type 2 diabetes mellitus	0.309	0.633	CbGaD
Flunisolide—CYP3A4—type 2 diabetes mellitus	0.179	0.367	CbGaD
Flunisolide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0423	0.152	CbGbCtD
Flunisolide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0377	0.136	CbGbCtD
Flunisolide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0345	0.124	CbGbCtD
Flunisolide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0301	0.109	CbGbCtD
Flunisolide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0272	0.0982	CbGbCtD
Flunisolide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0206	0.0744	CbGbCtD
Flunisolide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0198	0.0713	CbGbCtD
Flunisolide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0198	0.0713	CbGbCtD
Flunisolide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0187	0.0675	CbGbCtD
Flunisolide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0139	0.0503	CbGbCtD
Flunisolide—CYP3A4—Losartan—type 2 diabetes mellitus	0.0128	0.046	CbGbCtD
Flunisolide—Prednisone—HSD11B1—type 2 diabetes mellitus	0.000664	0.112	CrCbGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—type 2 diabetes mellitus	0.000315	0.00859	CbGpPWpGaD
Flunisolide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—type 2 diabetes mellitus	0.00031	0.00845	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—LEP—type 2 diabetes mellitus	0.000308	0.0084	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—RETN—type 2 diabetes mellitus	0.000306	0.00833	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYB5R4—type 2 diabetes mellitus	0.0003	0.00818	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—CPT1A—type 2 diabetes mellitus	0.000297	0.0081	CbGpPWpGaD
Flunisolide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—type 2 diabetes mellitus	0.000296	0.00806	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—NAMPT—type 2 diabetes mellitus	0.000291	0.00794	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—AR—type 2 diabetes mellitus	0.000277	0.00755	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—F7—type 2 diabetes mellitus	0.000276	0.00753	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—type 2 diabetes mellitus	0.000275	0.0075	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—type 2 diabetes mellitus	0.000268	0.00732	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.000268	0.0073	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—type 2 diabetes mellitus	0.000266	0.00726	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000264	0.0072	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—type 2 diabetes mellitus	0.000263	0.00717	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—SREBF1—type 2 diabetes mellitus	0.00026	0.00708	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—ATF3—type 2 diabetes mellitus	0.000254	0.00691	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000246	0.0067	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000246	0.0067	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—HNF1A—type 2 diabetes mellitus	0.000242	0.00659	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.000226	0.00615	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.000223	0.00608	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.000222	0.00607	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.000219	0.00596	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000218	0.00594	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.000214	0.00584	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.000212	0.00578	CbGpPWpGaD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—type 2 diabetes mellitus	0.000211	0.00575	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.00021	0.00572	CbGpPWpGaD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—type 2 diabetes mellitus	0.000209	0.00569	CbGpPWpGaD
Flunisolide—Difluprednate—NR3C1—type 2 diabetes mellitus	0.000204	0.0345	CrCbGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.000203	0.00553	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000202	0.00552	CbGpPWpGaD
Flunisolide—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000198	0.0334	CrCbGaD
Flunisolide—Clocortolone—NR3C1—type 2 diabetes mellitus	0.000198	0.0334	CrCbGaD
Flunisolide—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000194	0.00529	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.000193	0.00527	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000191	0.00522	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—CYP1A2—type 2 diabetes mellitus	0.00019	0.00518	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000189	0.00515	CbGpPWpGaD
Flunisolide—Desonide—NR3C1—type 2 diabetes mellitus	0.000187	0.0316	CrCbGaD
Flunisolide—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000187	0.0316	CrCbGaD
Flunisolide—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000183	0.0308	CrCbGaD
Flunisolide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—type 2 diabetes mellitus	0.000182	0.00496	CbGpPWpGaD
Flunisolide—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000181	0.0305	CrCbGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	0.000178	0.00486	CbGpPWpGaD
Flunisolide—CYP3A4—Xenobiotics—CYP2E1—type 2 diabetes mellitus	0.000177	0.00481	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000175	0.00477	CbGpPWpGaD
Flunisolide—CYP3A4—Xenobiotics—CYP1A2—type 2 diabetes mellitus	0.000175	0.00476	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000173	0.00473	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000171	0.00467	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	0.00017	0.00463	CbGpPWpGaD
Flunisolide—CYP3A4—Tamoxifen metabolism—CYP2E1—type 2 diabetes mellitus	0.00017	0.00463	CbGpPWpGaD
Flunisolide—CYP3A4—Tamoxifen metabolism—CYP1A2—type 2 diabetes mellitus	0.000168	0.00458	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000166	0.00452	CbGpPWpGaD
Flunisolide—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.00016	0.027	CrCbGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.00016	0.00435	CbGpPWpGaD
Flunisolide—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.000157	0.0266	CrCbGaD
Flunisolide—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.000156	0.00425	CbGpPWpGaD
Flunisolide—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000155	0.0261	CrCbGaD
Flunisolide—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000152	0.00414	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.000151	0.00412	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.000151	0.00412	CbGpPWpGaD
Flunisolide—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—type 2 diabetes mellitus	0.00015	0.0041	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.00015	0.00409	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.000146	0.00399	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.000146	0.00397	CbGpPWpGaD
Flunisolide—Infection—Orlistat—type 2 diabetes mellitus	0.000145	0.000757	CcSEcCtD
Flunisolide—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000145	0.000756	CcSEcCtD
Flunisolide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000145	0.000753	CcSEcCtD
Flunisolide—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000144	0.0243	CrCbGaD
Flunisolide—Budesonide—NR3C1—type 2 diabetes mellitus	0.000144	0.0243	CrCbGaD
Flunisolide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000144	0.00075	CcSEcCtD
Flunisolide—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000144	0.000748	CcSEcCtD
Flunisolide—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000144	0.000748	CcSEcCtD
Flunisolide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000143	0.000747	CcSEcCtD
Flunisolide—Agitation—Irbesartan—type 2 diabetes mellitus	0.000143	0.000746	CcSEcCtD
Flunisolide—Hypertension—Metformin—type 2 diabetes mellitus	0.000143	0.000743	CcSEcCtD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.000143	0.00389	CbGpPWpGaD
Flunisolide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000143	0.000743	CcSEcCtD
Flunisolide—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000142	0.000742	CcSEcCtD
Flunisolide—Back pain—Losartan—type 2 diabetes mellitus	0.000142	0.000739	CcSEcCtD
Flunisolide—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000142	0.000739	CcSEcCtD
Flunisolide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000142	0.000739	CcSEcCtD
Flunisolide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000141	0.000737	CcSEcCtD
Flunisolide—Fluticasone furoate—NR3C1—type 2 diabetes mellitus	0.000141	0.0238	CrCbGaD
Flunisolide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000141	0.000734	CcSEcCtD
Flunisolide—Chest pain—Metformin—type 2 diabetes mellitus	0.000141	0.000733	CcSEcCtD
Flunisolide—Myalgia—Metformin—type 2 diabetes mellitus	0.000141	0.000733	CcSEcCtD
Flunisolide—Malaise—Irbesartan—type 2 diabetes mellitus	0.000141	0.000732	CcSEcCtD
Flunisolide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00014	0.00073	CcSEcCtD
Flunisolide—Headache—Pioglitazone—type 2 diabetes mellitus	0.00014	0.000729	CcSEcCtD
Flunisolide—Syncope—Irbesartan—type 2 diabetes mellitus	0.00014	0.000728	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000139	0.0038	CbGpPWpGaD
Flunisolide—Discomfort—Metformin—type 2 diabetes mellitus	0.000139	0.000724	CcSEcCtD
Flunisolide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000139	0.000724	CcSEcCtD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.000139	0.00378	CbGpPWpGaD
Flunisolide—Nausea—Glipizide—type 2 diabetes mellitus	0.000138	0.000721	CcSEcCtD
Flunisolide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000138	0.000721	CcSEcCtD
Flunisolide—Vision blurred—Losartan—type 2 diabetes mellitus	0.000138	0.00072	CcSEcCtD
Flunisolide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000138	0.000718	CcSEcCtD
Flunisolide—Pain—Gliclazide—type 2 diabetes mellitus	0.000138	0.000718	CcSEcCtD
Flunisolide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000138	0.000718	CcSEcCtD
Flunisolide—Tremor—Losartan—type 2 diabetes mellitus	0.000137	0.000716	CcSEcCtD
Flunisolide—Rash—Glimepiride—type 2 diabetes mellitus	0.000137	0.000715	CcSEcCtD
Flunisolide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000137	0.000714	CcSEcCtD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000137	0.00374	CbGpPWpGaD
Flunisolide—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000137	0.000714	CcSEcCtD
Flunisolide—Mometasone—NR3C1—type 2 diabetes mellitus	0.000137	0.0231	CrCbGaD
Flunisolide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000137	0.000712	CcSEcCtD
Flunisolide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000137	0.000712	CcSEcCtD
Flunisolide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000137	0.000712	CcSEcCtD
Flunisolide—Headache—Glimepiride—type 2 diabetes mellitus	0.000136	0.00071	CcSEcCtD
Flunisolide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000136	0.000709	CcSEcCtD
Flunisolide—Cough—Irbesartan—type 2 diabetes mellitus	0.000136	0.000709	CcSEcCtD
Flunisolide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000136	0.000708	CcSEcCtD
Flunisolide—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000135	0.0228	CrCbGaD
Flunisolide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000135	0.000703	CcSEcCtD
Flunisolide—Agitation—Losartan—type 2 diabetes mellitus	0.000135	0.000702	CcSEcCtD
Flunisolide—Oedema—Metformin—type 2 diabetes mellitus	0.000135	0.000702	CcSEcCtD
Flunisolide—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000135	0.000701	CcSEcCtD
Flunisolide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000134	0.0007	CcSEcCtD
Flunisolide—Infection—Metformin—type 2 diabetes mellitus	0.000134	0.000698	CcSEcCtD
Flunisolide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000134	0.000698	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000133	0.000694	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.000133	0.00363	CbGpPWpGaD
Flunisolide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000133	0.000692	CcSEcCtD
Flunisolide—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000133	0.000691	CcSEcCtD
Flunisolide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000133	0.000691	CcSEcCtD
Flunisolide—Shock—Metformin—type 2 diabetes mellitus	0.000133	0.000691	CcSEcCtD
Flunisolide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000132	0.000689	CcSEcCtD
Flunisolide—Malaise—Losartan—type 2 diabetes mellitus	0.000132	0.000689	CcSEcCtD
Flunisolide—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000132	0.000689	CcSEcCtD
Flunisolide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000132	0.000689	CcSEcCtD
Flunisolide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000132	0.000688	CcSEcCtD
Flunisolide—Vertigo—Losartan—type 2 diabetes mellitus	0.000132	0.000687	CcSEcCtD
Flunisolide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000132	0.000686	CcSEcCtD
Flunisolide—Syncope—Losartan—type 2 diabetes mellitus	0.000132	0.000685	CcSEcCtD
Flunisolide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000131	0.000683	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.00013	0.00356	CbGpPWpGaD
Flunisolide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00013	0.000679	CcSEcCtD
Flunisolide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00013	0.000679	CcSEcCtD
Flunisolide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00013	0.000676	CcSEcCtD
Flunisolide—Palpitations—Losartan—type 2 diabetes mellitus	0.00013	0.000675	CcSEcCtD
Flunisolide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000129	0.000673	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000129	0.00352	CbGpPWpGaD
Flunisolide—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000129	0.000672	CcSEcCtD
Flunisolide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000671	CcSEcCtD
Flunisolide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000129	0.000671	CcSEcCtD
Flunisolide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000129	0.000671	CcSEcCtD
Flunisolide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000129	0.00067	CcSEcCtD
Flunisolide—Cough—Losartan—type 2 diabetes mellitus	0.000128	0.000667	CcSEcCtD
Flunisolide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000128	0.000667	CcSEcCtD
Flunisolide—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.000128	0.0215	CrCbGaD
Flunisolide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000128	0.000665	CcSEcCtD
Flunisolide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000127	0.000664	CcSEcCtD
Flunisolide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000127	0.000664	CcSEcCtD
Flunisolide—Oedema—Irbesartan—type 2 diabetes mellitus	0.000127	0.000663	CcSEcCtD
Flunisolide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000127	0.000662	CcSEcCtD
Flunisolide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000127	0.000661	CcSEcCtD
Flunisolide—Constipation—Valsartan—type 2 diabetes mellitus	0.000127	0.000659	CcSEcCtD
Flunisolide—Infection—Irbesartan—type 2 diabetes mellitus	0.000126	0.000658	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.000126	0.00344	CbGpPWpGaD
Flunisolide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000126	0.000657	CcSEcCtD
Flunisolide—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000126	0.000655	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000126	0.00343	CbGpPWpGaD
Flunisolide—Shock—Irbesartan—type 2 diabetes mellitus	0.000125	0.000652	CcSEcCtD
Flunisolide—Pain—Orlistat—type 2 diabetes mellitus	0.000125	0.000652	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000125	0.00341	CbGpPWpGaD
Flunisolide—Chest pain—Losartan—type 2 diabetes mellitus	0.000125	0.000651	CcSEcCtD
Flunisolide—Myalgia—Losartan—type 2 diabetes mellitus	0.000125	0.000651	CcSEcCtD
Flunisolide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000125	0.00065	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.000125	0.0034	CbGpPWpGaD
Flunisolide—Anxiety—Losartan—type 2 diabetes mellitus	0.000124	0.000648	CcSEcCtD
Flunisolide—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000124	0.000647	CcSEcCtD
Flunisolide—Alclometasone—NR3C1—type 2 diabetes mellitus	0.000124	0.0209	CrCbGaD
Flunisolide—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.000124	0.0209	CrCbGaD
Flunisolide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000124	0.000645	CcSEcCtD
Flunisolide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000124	0.000644	CcSEcCtD
Flunisolide—Discomfort—Losartan—type 2 diabetes mellitus	0.000123	0.000643	CcSEcCtD
Flunisolide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000123	0.000642	CcSEcCtD
Flunisolide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000123	0.000641	CcSEcCtD
Flunisolide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000123	0.000641	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000123	0.00064	CcSEcCtD
Flunisolide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000123	0.00064	CcSEcCtD
Flunisolide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000121	0.000631	CcSEcCtD
Flunisolide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000121	0.000628	CcSEcCtD
Flunisolide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00012	0.000626	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.00012	0.00327	CbGpPWpGaD
Flunisolide—Oedema—Losartan—type 2 diabetes mellitus	0.00012	0.000624	CcSEcCtD
Flunisolide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00012	0.000623	CcSEcCtD
Flunisolide—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000119	0.0201	CrCbGaD
Flunisolide—Infection—Losartan—type 2 diabetes mellitus	0.000119	0.00062	CcSEcCtD
Flunisolide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000119	0.000618	CcSEcCtD
Flunisolide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000119	0.000618	CcSEcCtD
Flunisolide—Tremor—Ramipril—type 2 diabetes mellitus	0.000118	0.000614	CcSEcCtD
Flunisolide—Shock—Losartan—type 2 diabetes mellitus	0.000118	0.000614	CcSEcCtD
Flunisolide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000118	0.000613	CcSEcCtD
Flunisolide—Ciclesonide—NR3C1—type 2 diabetes mellitus	0.000117	0.0198	CrCbGaD
Flunisolide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	0.000117	0.0032	CbGpPWpGaD
Flunisolide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000117	0.00061	CcSEcCtD
Flunisolide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000117	0.00061	CcSEcCtD
Flunisolide—Tachycardia—Losartan—type 2 diabetes mellitus	0.000117	0.000609	CcSEcCtD
Flunisolide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000117	0.000608	CcSEcCtD
Flunisolide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000607	CcSEcCtD
Flunisolide—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.000116	0.0196	CrCbGaD
Flunisolide—Fatigue—Metformin—type 2 diabetes mellitus	0.000116	0.000605	CcSEcCtD
Flunisolide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000116	0.000605	CcSEcCtD
Flunisolide—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000116	0.00317	CbGpPWpGaD
Flunisolide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000116	0.000604	CcSEcCtD
Flunisolide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000116	0.000603	CcSEcCtD
Flunisolide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000116	0.000602	CcSEcCtD
Flunisolide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000116	0.000602	CcSEcCtD
Flunisolide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000116	0.000602	CcSEcCtD
Flunisolide—Agitation—Ramipril—type 2 diabetes mellitus	0.000116	0.000602	CcSEcCtD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000115	0.00315	CbGpPWpGaD
Flunisolide—Constipation—Metformin—type 2 diabetes mellitus	0.000115	0.000601	CcSEcCtD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000115	0.00314	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000114	0.00311	CbGpPWpGaD
Flunisolide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000114	0.000594	CcSEcCtD
Flunisolide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000114	0.000594	CcSEcCtD
Flunisolide—Malaise—Ramipril—type 2 diabetes mellitus	0.000113	0.000591	CcSEcCtD
Flunisolide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000113	0.000591	CcSEcCtD
Flunisolide—Rash—Glyburide—type 2 diabetes mellitus	0.000113	0.000589	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000113	0.00308	CbGpPWpGaD
Flunisolide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000113	0.000589	CcSEcCtD
Flunisolide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000113	0.000589	CcSEcCtD
Flunisolide—Syncope—Ramipril—type 2 diabetes mellitus	0.000113	0.000588	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000113	0.00307	CbGpPWpGaD
Flunisolide—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000113	0.019	CrCbGaD
Flunisolide—Headache—Glyburide—type 2 diabetes mellitus	0.000112	0.000586	CcSEcCtD
Flunisolide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000583	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000111	0.00303	CbGpPWpGaD
Flunisolide—Palpitations—Ramipril—type 2 diabetes mellitus	0.000111	0.000579	CcSEcCtD
Flunisolide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000111	0.000579	CcSEcCtD
Flunisolide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000111	0.000576	CcSEcCtD
Flunisolide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000111	0.000576	CcSEcCtD
Flunisolide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00011	0.000574	CcSEcCtD
Flunisolide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00011	0.000574	CcSEcCtD
Flunisolide—Cough—Ramipril—type 2 diabetes mellitus	0.00011	0.000572	CcSEcCtD
Flunisolide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00011	0.000571	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000109	0.000568	CcSEcCtD
Flunisolide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000109	0.000568	CcSEcCtD
Flunisolide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000109	0.000567	CcSEcCtD
Flunisolide—Pain—Irbesartan—type 2 diabetes mellitus	0.000109	0.000567	CcSEcCtD
Flunisolide—Insomnia—Losartan—type 2 diabetes mellitus	0.000108	0.000564	CcSEcCtD
Flunisolide—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000108	0.0182	CrCbGaD
Flunisolide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000108	0.000561	CcSEcCtD
Flunisolide—Urticaria—Metformin—type 2 diabetes mellitus	0.000107	0.000558	CcSEcCtD
Flunisolide—Myalgia—Ramipril—type 2 diabetes mellitus	0.000107	0.000558	CcSEcCtD
Flunisolide—Chest pain—Ramipril—type 2 diabetes mellitus	0.000107	0.000558	CcSEcCtD
Flunisolide—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000107	0.000556	CcSEcCtD
Flunisolide—Anxiety—Ramipril—type 2 diabetes mellitus	0.000107	0.000556	CcSEcCtD
Flunisolide—Nausea—Glyburide—type 2 diabetes mellitus	0.000107	0.000555	CcSEcCtD
Flunisolide—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000107	0.000555	CcSEcCtD
Flunisolide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000107	0.000555	CcSEcCtD
Flunisolide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000106	0.000553	CcSEcCtD
Flunisolide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000106	0.000551	CcSEcCtD
Flunisolide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000105	0.000549	CcSEcCtD
Flunisolide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000105	0.000547	CcSEcCtD
Flunisolide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000105	0.000546	CcSEcCtD
Flunisolide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000105	0.000546	CcSEcCtD
Flunisolide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000104	0.000542	CcSEcCtD
Flunisolide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000104	0.000542	CcSEcCtD
Flunisolide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000103	0.000539	CcSEcCtD
Flunisolide—Fatigue—Losartan—type 2 diabetes mellitus	0.000103	0.000538	CcSEcCtD
Flunisolide—Oedema—Ramipril—type 2 diabetes mellitus	0.000103	0.000535	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000103	0.0028	CbGpPWpGaD
Flunisolide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000102	0.000534	CcSEcCtD
Flunisolide—Pain—Losartan—type 2 diabetes mellitus	0.000102	0.000533	CcSEcCtD
Flunisolide—Constipation—Losartan—type 2 diabetes mellitus	0.000102	0.000533	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000102	0.00279	CbGpPWpGaD
Flunisolide—Hydrocortisone—SHBG—type 2 diabetes mellitus	0.000102	0.0172	CrCbGaD
Flunisolide—Rash—Gliclazide—type 2 diabetes mellitus	0.000102	0.000529	CcSEcCtD
Flunisolide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000101	0.000529	CcSEcCtD
Flunisolide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000101	0.000528	CcSEcCtD
Flunisolide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000101	0.000527	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.000101	0.00275	CbGpPWpGaD
Flunisolide—Shock—Ramipril—type 2 diabetes mellitus	0.000101	0.000526	CcSEcCtD
Flunisolide—Headache—Gliclazide—type 2 diabetes mellitus	0.000101	0.000526	CcSEcCtD
Flunisolide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000101	0.000524	CcSEcCtD
Flunisolide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000101	0.000524	CcSEcCtD
Flunisolide—Tachycardia—Ramipril—type 2 diabetes mellitus	0.0001	0.000522	CcSEcCtD
Flunisolide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.0001	0.000521	CcSEcCtD
Flunisolide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.92e-05	0.000517	CcSEcCtD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	9.9e-05	0.0027	CbGpPWpGaD
Flunisolide—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.86e-05	0.000514	CcSEcCtD
Flunisolide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.79e-05	0.00051	CcSEcCtD
Flunisolide—Dizziness—Valsartan—type 2 diabetes mellitus	9.79e-05	0.00051	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	9.75e-05	0.00266	CbGpPWpGaD
Flunisolide—Dizziness—Orlistat—type 2 diabetes mellitus	9.67e-05	0.000504	CcSEcCtD
Flunisolide—Asthenia—Metformin—type 2 diabetes mellitus	9.67e-05	0.000504	CcSEcCtD
Flunisolide—Nausea—Gliclazide—type 2 diabetes mellitus	9.57e-05	0.000499	CcSEcCtD
Flunisolide—Pruritus—Metformin—type 2 diabetes mellitus	9.54e-05	0.000497	CcSEcCtD
Flunisolide—Urticaria—Losartan—type 2 diabetes mellitus	9.51e-05	0.000495	CcSEcCtD
Flunisolide—Triamcinolone—NR3C1—type 2 diabetes mellitus	9.49e-05	0.016	CrCbGaD
Flunisolide—Body temperature increased—Losartan—type 2 diabetes mellitus	9.46e-05	0.000493	CcSEcCtD
Flunisolide—Abdominal pain—Losartan—type 2 diabetes mellitus	9.46e-05	0.000493	CcSEcCtD
Flunisolide—Vomiting—Valsartan—type 2 diabetes mellitus	9.41e-05	0.00049	CcSEcCtD
Flunisolide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.37e-05	0.000488	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000487	CcSEcCtD
Flunisolide—Rash—Valsartan—type 2 diabetes mellitus	9.33e-05	0.000486	CcSEcCtD
Flunisolide—Dermatitis—Valsartan—type 2 diabetes mellitus	9.32e-05	0.000486	CcSEcCtD
Flunisolide—Vomiting—Orlistat—type 2 diabetes mellitus	9.3e-05	0.000485	CcSEcCtD
Flunisolide—Insomnia—Ramipril—type 2 diabetes mellitus	9.28e-05	0.000484	CcSEcCtD
Flunisolide—Headache—Valsartan—type 2 diabetes mellitus	9.27e-05	0.000483	CcSEcCtD
Flunisolide—Diarrhoea—Metformin—type 2 diabetes mellitus	9.22e-05	0.000481	CcSEcCtD
Flunisolide—Rash—Orlistat—type 2 diabetes mellitus	9.22e-05	0.00048	CcSEcCtD
Flunisolide—Dermatitis—Orlistat—type 2 diabetes mellitus	9.21e-05	0.00048	CcSEcCtD
Flunisolide—Headache—Orlistat—type 2 diabetes mellitus	9.16e-05	0.000477	CcSEcCtD
Flunisolide—Dyspnoea—Ramipril—type 2 diabetes mellitus	9.15e-05	0.000477	CcSEcCtD
Flunisolide—Asthenia—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.000476	CcSEcCtD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	9.07e-05	0.00247	CbGpPWpGaD
Flunisolide—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000471	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	9.01e-05	0.00246	CbGpPWpGaD
Flunisolide—Pruritus—Irbesartan—type 2 diabetes mellitus	9e-05	0.000469	CcSEcCtD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	8.96e-05	0.00244	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	8.95e-05	0.00244	CbGpPWpGaD
Flunisolide—Dexamethasone—NOS2—type 2 diabetes mellitus	8.94e-05	0.0151	CrCbGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	8.94e-05	0.00244	CbGpPWpGaD
Flunisolide—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.92e-05	0.000465	CcSEcCtD
Flunisolide—Dizziness—Metformin—type 2 diabetes mellitus	8.91e-05	0.000464	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	8.88e-05	0.00242	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	8.88e-05	0.00242	CbGpPWpGaD
Flunisolide—Fatigue—Ramipril—type 2 diabetes mellitus	8.85e-05	0.000461	CcSEcCtD
Flunisolide—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.82e-05	0.00046	CcSEcCtD
Flunisolide—Nausea—Valsartan—type 2 diabetes mellitus	8.79e-05	0.000458	CcSEcCtD
Flunisolide—Constipation—Ramipril—type 2 diabetes mellitus	8.78e-05	0.000457	CcSEcCtD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	8.76e-05	0.00239	CbGpPWpGaD
Flunisolide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.7e-05	0.000453	CcSEcCtD
Flunisolide—Nausea—Orlistat—type 2 diabetes mellitus	8.69e-05	0.000453	CcSEcCtD
Flunisolide—Prednisone—NR3C1—type 2 diabetes mellitus	8.61e-05	0.0145	CrCbGaD
Flunisolide—Asthenia—Losartan—type 2 diabetes mellitus	8.59e-05	0.000448	CcSEcCtD
Flunisolide—Vomiting—Metformin—type 2 diabetes mellitus	8.57e-05	0.000447	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	8.52e-05	0.00232	CbGpPWpGaD
Flunisolide—Rash—Metformin—type 2 diabetes mellitus	8.5e-05	0.000443	CcSEcCtD
Flunisolide—Dermatitis—Metformin—type 2 diabetes mellitus	8.49e-05	0.000442	CcSEcCtD
Flunisolide—Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	8.48e-05	0.0143	CrCbGaD
Flunisolide—Pruritus—Losartan—type 2 diabetes mellitus	8.47e-05	0.000441	CcSEcCtD
Flunisolide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.46e-05	0.000441	CcSEcCtD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	8.45e-05	0.0023	CbGpPWpGaD
Flunisolide—Headache—Metformin—type 2 diabetes mellitus	8.44e-05	0.00044	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	8.43e-05	0.0023	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	8.43e-05	0.0023	CbGpPWpGaD
Flunisolide—Dizziness—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.000438	CcSEcCtD
Flunisolide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.39e-05	0.000437	CcSEcCtD
Flunisolide—Budesonide—CYP3A4—type 2 diabetes mellitus	8.34e-05	0.0141	CrCbGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	8.31e-05	0.00227	CbGpPWpGaD
Flunisolide—Diarrhoea—Losartan—type 2 diabetes mellitus	8.19e-05	0.000427	CcSEcCtD
Flunisolide—Fluticasone furoate—CYP3A4—type 2 diabetes mellitus	8.18e-05	0.0138	CrCbGaD
Flunisolide—Urticaria—Ramipril—type 2 diabetes mellitus	8.15e-05	0.000425	CcSEcCtD
Flunisolide—Abdominal pain—Ramipril—type 2 diabetes mellitus	8.11e-05	0.000423	CcSEcCtD
Flunisolide—Body temperature increased—Ramipril—type 2 diabetes mellitus	8.11e-05	0.000423	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	8.11e-05	0.00221	CbGpPWpGaD
Flunisolide—Vomiting—Irbesartan—type 2 diabetes mellitus	8.09e-05	0.000421	CcSEcCtD
Flunisolide—Rash—Irbesartan—type 2 diabetes mellitus	8.02e-05	0.000418	CcSEcCtD
Flunisolide—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.01e-05	0.000417	CcSEcCtD
Flunisolide—Nausea—Metformin—type 2 diabetes mellitus	8.01e-05	0.000417	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	8e-05	0.00218	CbGpPWpGaD
Flunisolide—Headache—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.000415	CcSEcCtD
Flunisolide—Prednisolone—NR3C1—type 2 diabetes mellitus	7.94e-05	0.0134	CrCbGaD
Flunisolide—Dizziness—Losartan—type 2 diabetes mellitus	7.92e-05	0.000412	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	7.84e-05	0.00214	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	7.78e-05	0.00212	CbGpPWpGaD
Flunisolide—Betamethasone—NR3C1—type 2 diabetes mellitus	7.77e-05	0.0131	CrCbGaD
Flunisolide—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	7.62e-05	0.00208	CbGpPWpGaD
Flunisolide—Vomiting—Losartan—type 2 diabetes mellitus	7.61e-05	0.000397	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	7.6e-05	0.00207	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	7.59e-05	0.00207	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	7.59e-05	0.00207	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	7.58e-05	0.00207	CbGpPWpGaD
Flunisolide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000394	CcSEcCtD
Flunisolide—Nausea—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000394	CcSEcCtD
Flunisolide—Rash—Losartan—type 2 diabetes mellitus	7.55e-05	0.000393	CcSEcCtD
Flunisolide—Dermatitis—Losartan—type 2 diabetes mellitus	7.54e-05	0.000393	CcSEcCtD
Flunisolide—Headache—Losartan—type 2 diabetes mellitus	7.5e-05	0.000391	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	7.44e-05	0.00203	CbGpPWpGaD
Flunisolide—Asthenia—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000384	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	7.34e-05	0.002	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	7.33e-05	0.002	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	7.28e-05	0.00198	CbGpPWpGaD
Flunisolide—Pruritus—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000378	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	7.25e-05	0.00198	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	7.23e-05	0.00197	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	7.2e-05	0.00196	CbGpPWpGaD
Flunisolide—Alclometasone—CYP3A4—type 2 diabetes mellitus	7.19e-05	0.0121	CrCbGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	7.15e-05	0.00195	CbGpPWpGaD
Flunisolide—Nausea—Losartan—type 2 diabetes mellitus	7.11e-05	0.00037	CcSEcCtD
Flunisolide—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000366	CcSEcCtD
Flunisolide—Paramethasone—CYP3A4—type 2 diabetes mellitus	6.91e-05	0.0117	CrCbGaD
Flunisolide—Ciclesonide—CYP3A4—type 2 diabetes mellitus	6.8e-05	0.0115	CrCbGaD
Flunisolide—Dizziness—Ramipril—type 2 diabetes mellitus	6.79e-05	0.000354	CcSEcCtD
Flunisolide—Fluorometholone—CYP3A4—type 2 diabetes mellitus	6.75e-05	0.0114	CrCbGaD
Flunisolide—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	6.64e-05	0.00181	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	6.59e-05	0.0018	CbGpPWpGaD
Flunisolide—Vomiting—Ramipril—type 2 diabetes mellitus	6.53e-05	0.00034	CcSEcCtD
Flunisolide—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	6.52e-05	0.011	CrCbGaD
Flunisolide—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	6.48e-05	0.00177	CbGpPWpGaD
Flunisolide—Rash—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000337	CcSEcCtD
Flunisolide—Dermatitis—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000337	CcSEcCtD
Flunisolide—Headache—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000335	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	6.4e-05	0.00174	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	6.36e-05	0.00173	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	6.27e-05	0.00171	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	6.19e-05	0.00169	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	6.15e-05	0.00168	CbGpPWpGaD
Flunisolide—Nausea—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000318	CcSEcCtD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	6.09e-05	0.00166	CbGpPWpGaD
Flunisolide—Hydrocortisone—NR3C1—type 2 diabetes mellitus	6.07e-05	0.0102	CrCbGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	6.05e-05	0.00165	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	5.94e-05	0.00162	CbGpPWpGaD
Flunisolide—Dexamethasone—ABCC2—type 2 diabetes mellitus	5.93e-05	0.01	CrCbGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	5.88e-05	0.0016	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	5.84e-05	0.00159	CbGpPWpGaD
Flunisolide—Triamcinolone—CYP3A4—type 2 diabetes mellitus	5.5e-05	0.00928	CrCbGaD
Flunisolide—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	5.45e-05	0.00149	CbGpPWpGaD
Flunisolide—Triamcinolone—PTGS2—type 2 diabetes mellitus	5.39e-05	0.00909	CrCbGaD
Flunisolide—Prednisone—CYP3A4—type 2 diabetes mellitus	4.99e-05	0.00842	CrCbGaD
Flunisolide—Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	4.92e-05	0.0083	CrCbGaD
Flunisolide—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	4.68e-05	0.00127	CbGpPWpGaD
Flunisolide—Prednisolone—CYP3A4—type 2 diabetes mellitus	4.6e-05	0.00776	CrCbGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	4.56e-05	0.00124	CbGpPWpGaD
Flunisolide—Dexamethasone—NR3C1—type 2 diabetes mellitus	4.52e-05	0.00763	CrCbGaD
Flunisolide—Betamethasone—CYP3A4—type 2 diabetes mellitus	4.51e-05	0.0076	CrCbGaD
Flunisolide—Betamethasone—PTGS2—type 2 diabetes mellitus	4.41e-05	0.00744	CrCbGaD
Flunisolide—Prednisone—ALB—type 2 diabetes mellitus	4.35e-05	0.00734	CrCbGaD
Flunisolide—Dexamethasone—CYP2E1—type 2 diabetes mellitus	4.16e-05	0.00702	CrCbGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	4.09e-05	0.00112	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	4.05e-05	0.0011	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	4.02e-05	0.00109	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	3.95e-05	0.00108	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	3.85e-05	0.00105	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	3.82e-05	0.00104	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	3.82e-05	0.00104	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	3.78e-05	0.00103	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	3.77e-05	0.00103	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	3.74e-05	0.00102	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	3.7e-05	0.00101	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	3.69e-05	0.001	CbGpPWpGaD
Flunisolide—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	3.52e-05	0.00593	CrCbGaD
Flunisolide—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	3.48e-05	0.000949	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	3.47e-05	0.000946	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	3.44e-05	0.000938	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.16e-05	0.000861	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.12e-05	0.000851	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.11e-05	0.000849	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.08e-05	0.000839	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	2.97e-05	0.000811	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	2.86e-05	0.000781	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	2.78e-05	0.000757	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	2.62e-05	0.000715	CbGpPWpGaD
Flunisolide—Dexamethasone—CYP3A4—type 2 diabetes mellitus	2.62e-05	0.00442	CrCbGaD
Flunisolide—Dexamethasone—PTGS2—type 2 diabetes mellitus	2.57e-05	0.00433	CrCbGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.4e-05	0.000654	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.39e-05	0.000652	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.37e-05	0.000645	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.36e-05	0.000643	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.29e-05	0.000625	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.29e-05	0.000625	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	2.25e-05	0.000614	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.13e-05	0.000581	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.95e-05	0.000532	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.82e-05	0.000497	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	1.82e-05	0.000496	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.68e-05	0.000457	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.66e-05	0.000452	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.59e-05	0.000435	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.59e-05	0.000435	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.51e-05	0.000412	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.51e-05	0.000412	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.46e-05	0.000399	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.44e-05	0.000393	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.38e-05	0.000376	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.33e-05	0.000363	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.33e-05	0.000363	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.29e-05	0.000351	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.29e-05	0.000351	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.29e-05	0.000351	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.29e-05	0.000351	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.29e-05	0.000351	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.24e-05	0.000339	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.18e-05	0.000321	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.18e-05	0.000321	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.15e-05	0.000312	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	1.14e-05	0.000311	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.09e-05	0.000298	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.09e-05	0.000298	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.09e-05	0.000298	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.05e-05	0.000286	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.05e-05	0.000286	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.03e-05	0.00028	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.01e-05	0.000275	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.01e-05	0.000275	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.91e-06	0.00027	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.74e-06	0.000266	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.74e-06	0.000266	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.74e-06	0.000266	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.16e-06	0.00025	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.58e-06	0.000234	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	8.28e-06	0.000226	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	8.28e-06	0.000226	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	8.28e-06	0.000226	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	8.28e-06	0.000226	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.94e-06	0.000217	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.38e-06	0.000201	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.89e-06	0.000188	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.75e-06	0.000184	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.75e-06	0.000184	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.62e-06	0.000181	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.58e-06	0.000179	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.58e-06	0.000179	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.58e-06	0.000179	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.54e-06	0.000178	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.42e-06	0.000175	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.35e-06	0.000173	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.9e-06	0.000161	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.9e-06	0.000161	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.9e-06	0.000161	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.79e-06	0.000158	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.74e-06	0.000157	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.62e-06	0.000153	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.4e-06	0.000147	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.34e-06	0.000146	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.34e-06	0.000146	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.12e-06	0.00014	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.12e-06	0.00014	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	4.5e-06	0.000123	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.41e-06	0.00012	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.41e-06	0.00012	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.39e-06	0.00012	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.33e-06	0.000118	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.21e-06	0.000115	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.09e-06	0.000112	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.02e-06	0.000109	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.93e-06	0.000107	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.92e-06	0.000107	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.82e-06	0.000104	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.77e-06	0.000103	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.62e-06	9.86e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.55e-06	9.67e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.44e-06	9.37e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.38e-06	9.21e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.37e-06	9.18e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.33e-06	9.07e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.93e-06	7.99e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.88e-06	7.84e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.64e-06	7.19e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.52e-06	6.88e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.52e-06	6.88e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.31e-06	6.29e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	3.16e-05	CbGpPWpGaD
